Follow the fashion: the biotech financing model has changed. But will today’s start-ups be tomorrow’s fashion victims?

Today France Biotech celebrates its tenth birthday at the Eurobio Show in Lille. And the picture has never been rosier.

Nordforsk, the funding agency of the Nordic Council of Ministers, has funded the coordination of a network on biomedical imaging.

After a decade of withering in the shade of genetically modified crops, plant sciences are back on the political agenda in Europe follow the launch this week of a new Strategic Research Agenda.

India’s biotech sector is powering ahead, with 30 per cent annual growth over the past four years. But venture capitalists are still not tempted to invest.

The claim that over-patenting hinders the development of new treatments is not supported by the evidence, says the US Biotechnology Industry Organization.

The US biotechnology industry has gone through more than three years of sustained IPO financings, but that news isn’t all rosy for the industry.

French biotech consultants Bionest Partners has a system for valuing loss-making biotech companies using information available on a company website.